SMNR
SEMNUR PHARMS INC by Semnur Pharmaceuticals Inc. (SMNR)
$80
About SEMNUR PHARMS INC by Semnur Pharmaceuticals Inc. (SMNR)
Semnur Pharmaceuticals, Inc. engages in developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. It offers the product, SP-102, a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain. The company was founded in 2013 and is headquartered in Palo Alto, CA.
Details
Daily high
$0.80
Daily low
$0.62
Price at open
$0.62
52 Week High
$23.00
52 Week Low
$0.25
Market cap
193.4M
Dividend yield
-
Volume
2,740
Avg. volume
9,971
P/E ratio
-1.02
SEMNUR PHARMS INC by Semnur Pharmaceuticals Inc. News
Details
Daily high
$0.80
Daily low
$0.62
Price at open
$0.62
52 Week High
$23.00
52 Week Low
$0.25
Market cap
193.4M
Dividend yield
-
Volume
2,740
Avg. volume
9,971
P/E ratio
-1.02